Quinalizarin as a potent, selective and cell-permeable inhibitor of protein kinase CK2

Apoptosis; CK2 inhibitor; Drug design; Homeodomaininteracting protein kinase-2 (HIPK2); Provirus integration site for Moloney murine leukaemia virus 1 (PIM1); Quinalizarin; Animals; Anthraquinones; Apoptosis; Binding Sites; Casein Kinase II; Cell Line; Crystallography, X-Ray; Humans; Jurkat Cells; Kinetics; Molecular Conformation; Protein Kinase Inhibitors; Rats; Biochemistry; Cell Biology; Molecular Biology; Medicine (all)